Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 26 entries
Sorted by: Best Match Show Resources per page
Glutathione combined with mecobalamin in the treatment of chemotherapy-induced peripheral neuropathy in multiple myeloma: a retrospective clinical study.

Annals of palliative medicine

Huang H, Zhao M, Liu X, Song J, Liu L, Liu Y, Xiang P, Wang Y, Fang B.
PMID: 35016427
Ann Palliat Med. 2021 Dec;10(12):12335-12346. doi: 10.21037/apm-21-3313.

BACKGROUND: This study sought to examine the use of glutathione combined with mecobalamin in the prevention and treatment peripheral neuropathy (PN) in multiple myeloma (MM) patients, observe its effectiveness and safety, and explore the risk factors and prognostic factors...

Cite
Huang H, Zhao M, Liu X, et al. Glutathione combined with mecobalamin in the treatment of chemotherapy-induced peripheral neuropathy in multiple myeloma: a retrospective clinical study. Ann Palliat Med. 2021;10(12):12335-12346doi: 10.21037/apm-21-3313.
Huang, H., Zhao, M., Liu, X., Song, J., Liu, L., Liu, Y., Xiang, P., Wang, Y., & Fang, B. (2021). Glutathione combined with mecobalamin in the treatment of chemotherapy-induced peripheral neuropathy in multiple myeloma: a retrospective clinical study. Annals of palliative medicine, 10(12), 12335-12346. https://doi.org/10.21037/apm-21-3313
Huang, Hao, et al. "Glutathione combined with mecobalamin in the treatment of chemotherapy-induced peripheral neuropathy in multiple myeloma: a retrospective clinical study." Annals of palliative medicine vol. 10,12 (2021): 12335-12346. doi: https://doi.org/10.21037/apm-21-3313
Huang H, Zhao M, Liu X, Song J, Liu L, Liu Y, Xiang P, Wang Y, Fang B. Glutathione combined with mecobalamin in the treatment of chemotherapy-induced peripheral neuropathy in multiple myeloma: a retrospective clinical study. Ann Palliat Med. 2021 Dec;10(12):12335-12346. doi: 10.21037/apm-21-3313. PMID: 35016427.
Copy Download .nbib Format: NLM
Restorative effect and mechanism of mecobalamin on sciatic nerve crush injury in mice.

Neural regeneration research

Gan L, Qian M, Shi K, Chen G, Gu Y, Du W, Zhu G.
PMID: 25598780
Neural Regen Res. 2014 Nov 15;9(22):1979-84. doi: 10.4103/1673-5374.145379.

Mecobalamin, a form of vitamin B12 containing a central metal element (cobalt), is one of the most important mediators of nervous system function. In the clinic, it is often used to accelerate recovery of peripheral nerves, but its molecular...

Cite
Gan L, Qian M, Shi K, et al. Restorative effect and mechanism of mecobalamin on sciatic nerve crush injury in mice. Neural Regen Res. 2014;9(22):1979-84doi: 10.4103/1673-5374.145379.
Gan, L., Qian, M., Shi, K., Chen, G., Gu, Y., Du, W., & Zhu, G. (2014). Restorative effect and mechanism of mecobalamin on sciatic nerve crush injury in mice. Neural regeneration research, 9(22), 1979-84. https://doi.org/10.4103/1673-5374.145379
Gan, Lin, et al. "Restorative effect and mechanism of mecobalamin on sciatic nerve crush injury in mice." Neural regeneration research vol. 9,22 (2014): 1979-84. doi: https://doi.org/10.4103/1673-5374.145379
Gan L, Qian M, Shi K, Chen G, Gu Y, Du W, Zhu G. Restorative effect and mechanism of mecobalamin on sciatic nerve crush injury in mice. Neural Regen Res. 2014 Nov 15;9(22):1979-84. doi: 10.4103/1673-5374.145379. PMID: 25598780; PMCID: PMC4283280.
Copy Download .nbib Format: NLM
Effects of Oral Vitamin B1 and Mecobalamin on Dry Eye Disease.

Journal of ophthalmology

Ren X, Chou Y, Jiang X, Hao R, Wang Y, Chen Y, Li X.
PMID: 33005449
J Ophthalmol. 2020 Sep 09;2020:9539674. doi: 10.1155/2020/9539674. eCollection 2020.

PURPOSE: To assess the effects of oral vitamin B1 and mecobalamin on dry eye disease (DED) and patient satisfaction with treatment.METHODS: In this randomized controlled study, DED patients were divided into 4 groups based on treatment: group 1, only...

Cite
Ren X, Chou Y, Jiang X, et al. Effects of Oral Vitamin B1 and Mecobalamin on Dry Eye Disease. J Ophthalmol. 2020;2020:9539674doi: 10.1155/2020/9539674.
Ren, X., Chou, Y., Jiang, X., Hao, R., Wang, Y., Chen, Y., & Li, X. (2020). Effects of Oral Vitamin B1 and Mecobalamin on Dry Eye Disease. Journal of ophthalmology, 20209539674. https://doi.org/10.1155/2020/9539674
Ren, Xiaotong, et al. "Effects of Oral Vitamin B1 and Mecobalamin on Dry Eye Disease." Journal of ophthalmology vol. 2020 (2020): 9539674. doi: https://doi.org/10.1155/2020/9539674
Ren X, Chou Y, Jiang X, Hao R, Wang Y, Chen Y, Li X. Effects of Oral Vitamin B1 and Mecobalamin on Dry Eye Disease. J Ophthalmol. 2020 Sep 09;2020:9539674. doi: 10.1155/2020/9539674. eCollection 2020. PMID: 33005449; PMCID: PMC7508221.
Copy Download .nbib Format: NLM
Clinical Evaluation and Therapeutic Effects of Combination Treatment with Mecobalamin + Vitamin E in Recurrent Oral Ulcer.

Clinical therapeutics

Cui J, Lin W, Ma X, Wang J.
PMID: 34930660
Clin Ther. 2021 Dec 18; doi: 10.1016/j.clinthera.2021.10.015. Epub 2021 Dec 18.

PURPOSE: Recurrent oral ulcer is one of the most prevalent inflammatory ulcerative disorders of the oral mucosa. Due to the indeterminant cause and unpredictable course of the disease, clinical treatment of patients with recurrent oral ulcer is focused on...

Cite
Cui J, Lin W, Ma X, et al. Clinical Evaluation and Therapeutic Effects of Combination Treatment with Mecobalamin + Vitamin E in Recurrent Oral Ulcer. Clin Ther. 2021;doi: 10.1016/j.clinthera.2021.10.015.
Cui, J., Lin, W., Ma, X., & Wang, J. (2021). Clinical Evaluation and Therapeutic Effects of Combination Treatment with Mecobalamin + Vitamin E in Recurrent Oral Ulcer. Clinical therapeutics, . https://doi.org/10.1016/j.clinthera.2021.10.015
Cui, Juanjuan, et al. "Clinical Evaluation and Therapeutic Effects of Combination Treatment with Mecobalamin + Vitamin E in Recurrent Oral Ulcer." Clinical therapeutics vol. (2021). doi: https://doi.org/10.1016/j.clinthera.2021.10.015
Cui J, Lin W, Ma X, Wang J. Clinical Evaluation and Therapeutic Effects of Combination Treatment with Mecobalamin + Vitamin E in Recurrent Oral Ulcer. Clin Ther. 2021 Dec 18; doi: 10.1016/j.clinthera.2021.10.015. Epub 2021 Dec 18. PMID: 34930660.
Copy Download .nbib Format: NLM
The independent association between vitamin B12 and insomnia in Chinese patients with type 2 diabetes mellitus: a cross-sectional study.

Nutrition & diabetes

Xiong S, Liu Z, Yao N, Zhang X, Ge Q.
PMID: 35039481
Nutr Diabetes. 2022 Jan 17;12(1):3. doi: 10.1038/s41387-022-00181-8.

BACKGROUND/OBJECTIVES: Insomnia is highly prevalent in patients with type 2 diabetes mellitus (T2DM). This study therefore evaluated the associations between various micronutrients and insomnia in patients with T2DM.SUBJECTS/METHODS: Between January 2018 and December 2020, a total of 418 T2DM...

Cite
Xiong S, Liu Z, Yao N, et al. The independent association between vitamin B12 and insomnia in Chinese patients with type 2 diabetes mellitus: a cross-sectional study. Nutr Diabetes. 2022;12(1):3doi: 10.1038/s41387-022-00181-8.
Xiong, S., Liu, Z., Yao, N., Zhang, X., & Ge, Q. (2022). The independent association between vitamin B12 and insomnia in Chinese patients with type 2 diabetes mellitus: a cross-sectional study. Nutrition & diabetes, 12(1), 3. https://doi.org/10.1038/s41387-022-00181-8
Xiong, Shuyuan, et al. "The independent association between vitamin B12 and insomnia in Chinese patients with type 2 diabetes mellitus: a cross-sectional study." Nutrition & diabetes vol. 12,1 (2022): 3. doi: https://doi.org/10.1038/s41387-022-00181-8
Xiong S, Liu Z, Yao N, Zhang X, Ge Q. The independent association between vitamin B12 and insomnia in Chinese patients with type 2 diabetes mellitus: a cross-sectional study. Nutr Diabetes. 2022 Jan 17;12(1):3. doi: 10.1038/s41387-022-00181-8. PMID: 35039481.
Copy Download .nbib Format: NLM
Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.

PloS one

Hiramoto S, Asano H, Miyamoto T, Takegami M, Kawabata A.
PMID: 34972132
PLoS One. 2021 Dec 31;16(12):e0261473. doi: 10.1371/journal.pone.0261473. eCollection 2021.

Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse reaction in cancer patients treated with several cytotoxic anticancer agents including paclitaxel. Duloxetine, an antidepressant known as a serotonin-noradrenalin reuptake inhibitor, is the only agent that has moderate evidence for the...

Cite
Hiramoto S, Asano H, Miyamoto T, et al. Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan. PLoS One. 2021;16(12):e0261473doi: 10.1371/journal.pone.0261473.
Hiramoto, S., Asano, H., Miyamoto, T., Takegami, M., & Kawabata, A. (2021). Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan. PloS one, 16(12), e0261473. https://doi.org/10.1371/journal.pone.0261473
Hiramoto, Shiori, et al. "Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan." PloS one vol. 16,12 (2021): e0261473. doi: https://doi.org/10.1371/journal.pone.0261473
Hiramoto S, Asano H, Miyamoto T, Takegami M, Kawabata A. Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan. PLoS One. 2021 Dec 31;16(12):e0261473. doi: 10.1371/journal.pone.0261473. eCollection 2021. PMID: 34972132.
Copy Download .nbib Format: NLM
Case Report: Successful Outcome for Refractory Diabetic Peripheral Neuropathy in Patients With Ultrasound-Guided Injection Treatment.

Frontiers in endocrinology

Hu HQ, Huang H, Huang J, Leng JC, Li M, Tang C, Li Y, Wu S.
PMID: 34777245
Front Endocrinol (Lausanne). 2021 Oct 28;12:735132. doi: 10.3389/fendo.2021.735132. eCollection 2021.

Diabetic peripheral neuropathy is the most prevalent chronic complication of diabetes and is based on sensory and autonomic nerve symptoms. Generally, intensive glucose control and nerve nourishment are the main treatments. However, it is difficult to improve the symptoms...

Cite
Hu HQ, Huang H, Huang J, et al. Case Report: Successful Outcome for Refractory Diabetic Peripheral Neuropathy in Patients With Ultrasound-Guided Injection Treatment. Front Endocrinol (Lausanne). 2021;12:735132doi: 10.3389/fendo.2021.735132.
Hu, H. Q., Huang, H., Huang, J., Leng, J. C., Li, M., Tang, C., Li, Y., & Wu, S. (2021). Case Report: Successful Outcome for Refractory Diabetic Peripheral Neuropathy in Patients With Ultrasound-Guided Injection Treatment. Frontiers in endocrinology, 12735132. https://doi.org/10.3389/fendo.2021.735132
Hu, Hua Qiong, et al. "Case Report: Successful Outcome for Refractory Diabetic Peripheral Neuropathy in Patients With Ultrasound-Guided Injection Treatment." Frontiers in endocrinology vol. 12 (2021): 735132. doi: https://doi.org/10.3389/fendo.2021.735132
Hu HQ, Huang H, Huang J, Leng JC, Li M, Tang C, Li Y, Wu S. Case Report: Successful Outcome for Refractory Diabetic Peripheral Neuropathy in Patients With Ultrasound-Guided Injection Treatment. Front Endocrinol (Lausanne). 2021 Oct 28;12:735132. doi: 10.3389/fendo.2021.735132. eCollection 2021. PMID: 34777245; PMCID: PMC8581352.
Copy Download .nbib Format: NLM
Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.

PloS one

Hiramoto S, Asano H, Miyamoto T, Takegami M, Kawabata A.
PMID: 34972132
PLoS One. 2021 Dec 31;16(12):e0261473. doi: 10.1371/journal.pone.0261473. eCollection 2021.

Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse reaction in cancer patients treated with several cytotoxic anticancer agents including paclitaxel. Duloxetine, an antidepressant known as a serotonin-noradrenalin reuptake inhibitor, is the only agent that has moderate evidence for the...

Cite
Hiramoto S, Asano H, Miyamoto T, et al. Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan. PLoS One. 2021;16(12):e0261473doi: 10.1371/journal.pone.0261473.
Hiramoto, S., Asano, H., Miyamoto, T., Takegami, M., & Kawabata, A. (2021). Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan. PloS one, 16(12), e0261473. https://doi.org/10.1371/journal.pone.0261473
Hiramoto, Shiori, et al. "Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan." PloS one vol. 16,12 (2021): e0261473. doi: https://doi.org/10.1371/journal.pone.0261473
Hiramoto S, Asano H, Miyamoto T, Takegami M, Kawabata A. Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan. PLoS One. 2021 Dec 31;16(12):e0261473. doi: 10.1371/journal.pone.0261473. eCollection 2021. PMID: 34972132; PMCID: PMC8719717.
Copy Download .nbib Format: NLM
Expression of Concern: Sato et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005;293(9):1082-1088.

JAMA

Bauchner H, Fontanarosa PB.
PMID: 25988460
JAMA. 2015 May 19;313(19):1914. doi: 10.1001/jama.2015.4722.

No abstract available.

Cite
Bauchner H, Fontanarosa PB. Expression of Concern: Sato et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005;293(9):1082-1088. JAMA. 2015;313(19):1914doi: 10.1001/jama.2015.4722.
Bauchner, H., & Fontanarosa, P. B. (2015). Expression of Concern: Sato et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005;293(9):1082-1088. JAMA, 313(19), 1914. https://doi.org/10.1001/jama.2015.4722
Bauchner, Howard, and Fontanarosa, Phil B. "Expression of Concern: Sato et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005;293(9):1082-1088." JAMA vol. 313,19 (2015): 1914. doi: https://doi.org/10.1001/jama.2015.4722
Bauchner H, Fontanarosa PB. Expression of Concern: Sato et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005;293(9):1082-1088. JAMA. 2015 May 19;313(19):1914. doi: 10.1001/jama.2015.4722. PMID: 25988460.
Copy Download .nbib Format: NLM
[A Case Report of Kampo Medicine Improving the Symptoms of Antiresorptive Agent-related Osteonecrosis of the Jaw (ARONJ)].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Yamazaki Y, Shimada M.
PMID: 34471013
Yakugaku Zasshi. 2021;141(9):1123-1127. doi: 10.1248/yakushi.21-00128.

A 56-year-old woman visited an oral surgery clinic in October X with sudden pain in the left mandible. She was diagnosed with left mandibular osteomyelitis based on head computed tomography examination findings. The pain did not reduce even with...

Cite
Yamazaki Y, Shimada M. [A Case Report of Kampo Medicine Improving the Symptoms of Antiresorptive Agent-related Osteonecrosis of the Jaw (ARONJ)]. Yakugaku Zasshi. 2021;141(9):1123-1127doi: 10.1248/yakushi.21-00128.
Yamazaki, Y., & Shimada, M. (2021). [A Case Report of Kampo Medicine Improving the Symptoms of Antiresorptive Agent-related Osteonecrosis of the Jaw (ARONJ)]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 141(9), 1123-1127. https://doi.org/10.1248/yakushi.21-00128
Yamazaki, Yoko, and Shimada, Masahiko. "[A Case Report of Kampo Medicine Improving the Symptoms of Antiresorptive Agent-related Osteonecrosis of the Jaw (ARONJ)]." Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan vol. 141,9 (2021): 1123-1127. doi: https://doi.org/10.1248/yakushi.21-00128
Yamazaki Y, Shimada M. [A Case Report of Kampo Medicine Improving the Symptoms of Antiresorptive Agent-related Osteonecrosis of the Jaw (ARONJ)]. Yakugaku Zasshi. 2021;141(9):1123-1127. doi: 10.1248/yakushi.21-00128. Japanese. PMID: 34471013.
Copy Download .nbib Format: NLM
Success with neurotropin in treating pediatric lower extremity pain induced by spinal cord injury after epidural anesthesia.

Journal of pain research

Zhu M, Zhou F, Li L, Yin Q, Qiu M, Zhang Y.
PMID: 28652804
J Pain Res. 2017 Jun 06;10:1391-1394. doi: 10.2147/JPR.S135037. eCollection 2017.

Spinal cord injury (SCI) complicated by epidural anesthesia, though rare, can result in neuropathic pain. However, the treatment for this kind of life-altering injury remains a challenge. A 7-year-old girl was referred with dyskinesia and severe pain in her...

Cite
Zhu M, Zhou F, Li L, et al. Success with neurotropin in treating pediatric lower extremity pain induced by spinal cord injury after epidural anesthesia. J Pain Res. 2017;10:1391-1394doi: 10.2147/JPR.S135037.
Zhu, M., Zhou, F., Li, L., Yin, Q., Qiu, M., & Zhang, Y. (2017). Success with neurotropin in treating pediatric lower extremity pain induced by spinal cord injury after epidural anesthesia. Journal of pain research, 101391-1394. https://doi.org/10.2147/JPR.S135037
Zhu, Mengye, et al. "Success with neurotropin in treating pediatric lower extremity pain induced by spinal cord injury after epidural anesthesia." Journal of pain research vol. 10 (2017): 1391-1394. doi: https://doi.org/10.2147/JPR.S135037
Zhu M, Zhou F, Li L, Yin Q, Qiu M, Zhang Y. Success with neurotropin in treating pediatric lower extremity pain induced by spinal cord injury after epidural anesthesia. J Pain Res. 2017 Jun 06;10:1391-1394. doi: 10.2147/JPR.S135037. eCollection 2017. PMID: 28652804; PMCID: PMC5476653.
Copy Download .nbib Format: NLM
Huangqi Guizhi Wuwu Decoction for treating diabetic peripheral neuropathy: a meta-analysis of 16 randomized controlled trials.

Neural regeneration research

Pang B, Zhao TY, Zhao LH, Wan F, Ye R, Zhou Q, Tian F, Tong XL.
PMID: 27651785
Neural Regen Res. 2016 Aug;11(8):1347-58. doi: 10.4103/1673-5374.189202.

OBJECTIVE: This meta-analysis was performed to systematically assess the efficacy and safety of the Chinese herbal medicine Huangqi Guizhi Wuwu Decoction (HGWWD) for treating diabetic peripheral neuropathy.DATA SOURCES: Six electronic databases, including the Cochrane Library, MEDLINE database, Chinese Biomedical...

Cite
Pang B, Zhao TY, Zhao LH, et al. Huangqi Guizhi Wuwu Decoction for treating diabetic peripheral neuropathy: a meta-analysis of 16 randomized controlled trials. Neural Regen Res. 2016;11(8):1347-58doi: 10.4103/1673-5374.189202.
Pang, B., Zhao, T. Y., Zhao, L. H., Wan, F., Ye, R., Zhou, Q., Tian, F., & Tong, X. L. (2016). Huangqi Guizhi Wuwu Decoction for treating diabetic peripheral neuropathy: a meta-analysis of 16 randomized controlled trials. Neural regeneration research, 11(8), 1347-58. https://doi.org/10.4103/1673-5374.189202
Pang, Bing, et al. "Huangqi Guizhi Wuwu Decoction for treating diabetic peripheral neuropathy: a meta-analysis of 16 randomized controlled trials." Neural regeneration research vol. 11,8 (2016): 1347-58. doi: https://doi.org/10.4103/1673-5374.189202
Pang B, Zhao TY, Zhao LH, Wan F, Ye R, Zhou Q, Tian F, Tong XL. Huangqi Guizhi Wuwu Decoction for treating diabetic peripheral neuropathy: a meta-analysis of 16 randomized controlled trials. Neural Regen Res. 2016 Aug;11(8):1347-58. doi: 10.4103/1673-5374.189202. PMID: 27651785; PMCID: PMC5020836.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 26 entries